Dodd's Tablets Extra Strength 500 mg
Natural health product licensed in Canada
- Other names
- Extra Strength Dodds
- Licence holder
- Stella Pharmaceutical Canada Inc.
- NPN or DIN-HM
- 02014610
- Status
- Inactive licence
- Licence date
- 9 October 2007
- Revision date
- 30 June 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Amidon, Hydroxypropyl methylcellulose, Stéarate de magnésium, Phosphate de calcium, dibasique, anhydre, Cire de Carnauba, Talc, Calcium Carbonate 90 DC, Triacétate de glycérol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | maximum: 8 Tous les jours |
Uses authorised in Canada
For prompt, effective relief from pain due to mascular backache and arthritic pain. Relieves muscular backache pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
It is hazardous to exceed the maximum dose of tablets per day, unless directed by a physician. If symptoms persist beyond 5 days, consult your physician. This package contains sufficient drug to serioulsy harm a child, therefore keeep safety out the reach of children. If pregnant or nursing, consult your physician before using ths drug. Children and teenagers should not use this medicine before a physician is consulted about Reyes Syndrome, a rare but serious illness. As 500 mg tablets is not a standard dosage unit product, use only on the advice of a physician. See enclosed package insert important information.
Source
Official Health Canada record, licence 02014610
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging